Athira Pharma Inc Cash Flow-to-Debt Ratio
Athira Pharma Inc cash flow-to-debt ratio. Athira Pharma Inc (ATHA) has a Cash Flow-to-Debt Ratio of -0.30x as of December 2025, meaning its operating cash flow of $-19.40 Million could theoretically repay 0% of its total liabilities ($64.36 Million) in one year. See Athira Pharma Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Athira Pharma Inc (2018–2025)
Cash flow-to-debt ratio of Athira Pharma Inc from 2018 to 2025. Historical debt coverage capacity for Athira Pharma Inc across 8 annual periods. Also explore ATHA net asset momentum to track the company's year-over-year net asset growth rate.
Athira Pharma Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
Athira Pharma Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Athira Pharma Inc. For the full cash flow conversion analysis, see Athira Pharma Inc (ATHA) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.71x | $-45.73 Million | $64.36 Million | ▲ +89.8% |
| 2024 | -6.97x | $-97.17 Million | $13.94 Million | ▼ -108.0% |
| 2023 | -3.35x | $-100.75 Million | $30.06 Million | ▼ -6.5% |
| 2022 | -3.15x | $-72.47 Million | $23.02 Million | ▲ +20.2% |
| 2021 | -3.95x | $-43.10 Million | $10.92 Million | ▲ +13.6% |
| 2020 | -4.57x | $-24.11 Million | $5.28 Million | ▼ -2594.6% |
| 2019 | -0.17x | $-3.71 Million | $21.91 Million | ▲ +25.1% |
| 2018 | -0.23x | $-4.48 Million | $19.82 Million | — |